Lifeward and Ottobock Care open six-month ReWalk 7 access programme
Lifeward and Ottobock Care launched a six-month programme across more than 50 U.S. clinics to broaden evaluation, reimbursement support, training and access for the ReWalk 7 exoskeleton.
Evidence notes
- Ottobock Care’s clinic network will support patient evaluation and staff training during the programme.
- The partners will coordinate reimbursement support alongside clinical access.
- The announcement describes a six-month national pilot rather than a permanent network-wide rollout.
Company context
Lifeward, formerly ReWalk Robotics, develops wearable robotic exoskeletons and rehabilitation technologies for people with mobility impairments.